Objectives: To explore healthcare professionals (HCPs) experiences and challenges in diagnosing suspected lower limb cellulitis.Setting: UK nationwide.Participants: 20 qualified HCPs, who had a minimum of 2 years clinical experience as an HCP in the national health service and had managed a clinical case of suspected cellulitis of the lower limb in the UK. HCPs were recruited from departments of dermatology (including a specialist cellulitis clinic), general practice, tissue viability, lymphoedema services, general surgery, emergency care and acute medicine. Purposive sampling was employed to ensure that participants included consultant doctors, trainee doctors and nurses across the specialties listed above. Participants were recruited thro...
Cellulitis is an infective/inflammatory skin condition costing 426,000 bed days per year. The legs a...
Background: Cellulitis is a potentially serious infection that commonly recurs. The identification o...
BackgroundThere is an emerging need to develop consistent outcomes in clinical trials to allow effec...
Introduction Lower limb cellulitis (cellulitis) affects 1 in 40 people annually in the United King...
Background: Cellulitis is a painful infection of the skin and underlying tissues, commonly affecting...
Background: Cellulitis can be a difficult diagnosis to make. 31% of patients admitted from the emerg...
Accurate diagnosis and recognition of predisposing factors has been shown to be challenging in lower...
Background: Suspected lower limb cellulitis presentations are commonly misdiagnoses, resulting in av...
Cellulitis is a common clinical condition that is often inaccurately diagnosed. Risk factors for th...
INTRODUCTION: Cellulitis is defined as inflammation of skin and subcutaneous tissue,characterised b...
Background: Cellulitis is responsible for over 400,000 bed days per year in the English National Hea...
Background Cellulitis is a painful infection of the skin and underlying tissues, commonly affecting ...
Background: Cellulitis is a common painful infection of the skin and underlying tissues that recurs ...
Background: This paper describes the results of a feasibility study for a randomised controlled tri...
INTRODUCTION: Cellulitis is a non-suppurative, invasive infection caused by bacteria that is charac...
Cellulitis is an infective/inflammatory skin condition costing 426,000 bed days per year. The legs a...
Background: Cellulitis is a potentially serious infection that commonly recurs. The identification o...
BackgroundThere is an emerging need to develop consistent outcomes in clinical trials to allow effec...
Introduction Lower limb cellulitis (cellulitis) affects 1 in 40 people annually in the United King...
Background: Cellulitis is a painful infection of the skin and underlying tissues, commonly affecting...
Background: Cellulitis can be a difficult diagnosis to make. 31% of patients admitted from the emerg...
Accurate diagnosis and recognition of predisposing factors has been shown to be challenging in lower...
Background: Suspected lower limb cellulitis presentations are commonly misdiagnoses, resulting in av...
Cellulitis is a common clinical condition that is often inaccurately diagnosed. Risk factors for th...
INTRODUCTION: Cellulitis is defined as inflammation of skin and subcutaneous tissue,characterised b...
Background: Cellulitis is responsible for over 400,000 bed days per year in the English National Hea...
Background Cellulitis is a painful infection of the skin and underlying tissues, commonly affecting ...
Background: Cellulitis is a common painful infection of the skin and underlying tissues that recurs ...
Background: This paper describes the results of a feasibility study for a randomised controlled tri...
INTRODUCTION: Cellulitis is a non-suppurative, invasive infection caused by bacteria that is charac...
Cellulitis is an infective/inflammatory skin condition costing 426,000 bed days per year. The legs a...
Background: Cellulitis is a potentially serious infection that commonly recurs. The identification o...
BackgroundThere is an emerging need to develop consistent outcomes in clinical trials to allow effec...